$113,293,528

General Services Administration·Federal Acquisition Service

to ABSS SOLUTIONS INC

biotechexpiredONGOING · MOD OF 2020 CONTRACT

WORK BEGAN2020-09-08·LATEST ACTION2026-05-01·SOURCEUSASPENDING·SOURCE IDCONT_AWD_47QFWA20C0012_4732_-NONE-_-NONE-

Award description

59MDW SCIENCE TECHNOLOGY START BIOMEDICAL R&D SERVICES

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Biomedical research and development services supporting the 59th Medical Wing's science and technology initiatives.

Sub-sectors

military-biomedical-rdlife-sciences-researchdefense-health-innovation

Why this matters

Military biomedical R&D underpins force readiness, medical countermeasures, and advanced healthcare capabilities for defense personnel.

Supply-chain signal

Ongoing contract signals sustained demand for specialized biomedical research talent and laboratory infrastructure supporting military health innovation.

U.S.–China competition angle

U.S. military biomedical R&D investments compete with peer adversaries in advanced medical technologies and biological countermeasures.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-27. Cost: $0.002892.

Period of performance

Start

2020-09-08

End

2025-09-25

Status

expired278 days ago

Recipient

ABSS SOLUTIONS INC

UEI XLKQNNU4EZE1

View full profile →

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_47QFWA20C0012_4732_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.